Study ID,Trial,Year,Title,Journal,Indication,Population,study.size,percentage.female,Drug.control,Drug.intervention,Drug.dose,Duration of medication,Aspirin dose,Blinding,,duration.of.follow.up,Outcome,age,smoker.number,smoker.percentage,dm.number,dm.percentage,htn.number,htn.percentage,lipid.number,lipid.percentage,prev.angina.number,prev.angina.percentage,prev.mi.number,prev.mi.percentage,prev.revasc.number,prev.revasc.percentage,prev.pci.number,prev.pci.percentage,prev.cabg.number,prev.cabg.percentage,prev.ischaemic stroke.or.tia.number,prev.ischaemic stroke.or.tia.percentage,prev.ischaemic stroke.number,prev.ischaemic stroke.percentage,prev.tia.number,prev.tia.precentage,known.af.number,known.af.percentage,unclassified.mi,ua.or.nstemi,stemi,nstemi,ua,TIA,Ischaemic.Stroke,number.female,no.of.men,women.intervention.event,women.intervention.no.event,women.control.event,women.control.no.event,men.intervention.event,men.intervention.no.event,men.control.event,men.control.no.event,Statistic,women.ce,women.ll,women.ul,men.ce,men.ll,men.ul,P value,Comment
54,CURE,2001,Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation,NEJM,ACS,Patients presenting to hospital within 24 hours after onset of symptoms and did not have ST elevation,12562,38.5,placebo,clopidogrel,300mg loading dose followed by 75mg once daily,"3 to 12 months (mean duration of treatment, 9 months)",,double-blind,intention to treat,12 months,"death from cardiovascular causes, non-fatal MI or stroke",64.2 ± 11.3,7631,60.7,2840,22.6,7392,58.8,,,,,4044,32.2,2246,17.9,,,,,,,,,,,,,,,,25.1,74.9,,,4836,7726,230,2190,259,2157,349,3490,463,3424,OR,0.88,0.73,1.06,0.75,0.65,0.87,,from JACC paper
23,COMMIT,2005,"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.",Lancet,ACS,"Patients admitted within 24 hours of suspected acute MI onset with ST elevation, left-bundle branch block, or ST depression.",45852,27.8,placebo,clopidogrel,75mg,Hospital discharge or 28 days. (mean 14.9 days),,double-blind,intention to treat,Hospital discharge or 28 days.,"death, reinfarction, stroke",61.3 ± 11.9,,,,,19838,43.3,,,,,3818,8.3,,,,,,,,,,,,,,,,,93.1,6.9,,,,12759,33093,847,5519,894,5499,1274,15321,1416,15082,OR,0.94,0.85,1.04,0.89,0.82,0.96,,from JACC paper
45,CLARITY-TIMI 28,2005,Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.,NEJM,ACS,Patients 18 to 75 years of age presenting within 12 hours after onset of STEMI,3491,19.7,placebo,clopidogrel,300mg loading dose followed by 75mg once daily,"Up to day of Coronary Angiography, day 8 or hospital discahrge, whichever came first",,double-blind,intention to treat,30 days,"TIMI grade 0 or 1 on angiography, death, recurrent MI",57.5 ± 10.3,1752,50.2,575,16.5,1514,43.4,1138,32.6,,,318,9.1,,,169,4.8,,,,,,,,,,,,,100,,,,,688,2803,59,293,83,253,203,1197,292,1111,OR,0.82,0.53,1.26,0.82,0.63,1.06,,from JACC paper
53,TRITON-TIMI 38,2007,Prasugrel versus clopidogrel in patients with acute coronary syndromes.,NEJM,ACS,Patients with acute coronary syndrome with scheduled PCI,13608,26,clopidogrel,prasugrel,60mg loading dose followed by 10mg once daily,"6 to 15 months (median duration of treatment, 14.5 months)",,double-blind,intention to treat,15 months,"death from cardiovascular causes, non-fatal MI or non-fatal stroke",61,5171,38,3130,23,8709,64,7620,56,,,2449,18,,,,,1021,7.5,,,,,,,,,,74,26,,,,,3523,10085,187,1516,231,1604,485,4625,590,4370,,,,,,,,,
51,PLATO,2009,Ticagrelor versus clopidogrel in patients with acute coronary syndromes.,NEJM,ACS,Patients hospitalized for an acute coronary syndrome with an onset of symptoms during previous 24 hours,18624,28.4,clopidogrel,ticagrelor,180mg loading dose followed by 90mg twice daily,12 months,,double-blind,intention to treat,12 months,"death from vascular causes, MI, stroke",62,6678,35.9,4662,25,12183,65.4,8689,46.7,,,3824,20.5,,,2492,13.4,1106,5.9,,,,,,,,,,,37.7,42.7,16.7,,,5288,13336,297,2358,348,2285,614,6064,739,5919,HR,0.83,0.71,0.97,0.85,0.76,0.95,0.82,reported
43,TRILOGY ACS,2012,Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.,NEJM,ACS,Patients under the age of 75 with NSTEMI or Unstable angina with final treatment strategy of medical management,7243,35.9,clopidogrel,prasugrel,30mg loading dose followed by 10mg once daily,30 months,,double-blind,intention to treat,30 months,"death from cardiovascular causes, MI, stroke",62,1698,23.4,2249,31.1,5820,80.4,4270,59,,,3191,44.1,,,2032,28.1,1119,15.4,,,,,,,,,,,,67.5,32.5,,,2600,4644,193,1117,191,1099,310,2000,387,1946,HR,1.02,0.8,1.29,0.86,0.72,1.03,0.29,reported
1 (b),CHANCE,2010,Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack,NEJM,Stroke,patients within 24 hours after the onset of minor ischemic stroke or high-risk TIA ,5170,33.8,placebo,clopidogrel,300mg initial dose followed by 75mg daily,90 days,,double-blind,intention to treat,90 days,"stroke, MI or death from cardiovascular causes",62.5,2221,43,1093,21.1,3399,65.7,573,11.1,184,3.6,96,1.9,,,,,,,1033,20,1033,20,174,3.4,96,1.9,,,,,,27.9,72.1,1750,3420,83,769,114,784,133,1599,193,1495,HR,0.79,0.59,1.05,0.65,0.52,0.81,0.37,reported
2,SPS3,2012,Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke,NEJM,Stroke,recent symptomatic lacunar infarcts identified by magnetic resonance imaging. ,3020,37,placebo,clopidogrel,75mg,3.4 years,325mg,double-blind,intention to treat,3.4 years,"stroke recurrence (any ischemic stroke or intracranial hemorrhage, including subdural hematomas) ",63,619,20.5,1102,36.5,2265,75,,,,,,,,,,,,,453,15,,,,,,,,,,,,3,97,1117,1903,39,537,42,499,86,855,96,866,HR,0.9,0.58,1.4,0.93,0.69,1.2,0.91,reported
